COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection

被引:7
作者
Suzuki, Ayako [1 ,2 ]
Efird, Jimmy T. [3 ]
Redding, Thomas S. [3 ]
Thompson, Andrew D. Jr Jr [3 ]
Press, Ashlyn M. [3 ]
Williams, Christina D. [3 ,4 ,5 ]
Hostler, Christopher J. [6 ,7 ]
Hunt, Christine M. [1 ,2 ,3 ]
机构
[1] Duke Univ, Div Gastroenterol, Durham, NC 27710 USA
[2] Durham VA Med Ctr, Div Gastroenterol, Durham, NC 27705 USA
[3] Durham VA Hlth Care Syst, VA Cooperat Studies Program Epidemiol Ctr, Durham, NC 27705 USA
[4] Duke Univ, Dept Med, Durham, NC 27710 USA
[5] Duke Univ Hlth Care Syst, Duke Univ Sch Med, Duke Canc Inst, Durham, NC 27710 USA
[6] Duke Univ, Div Infect Dis, Sch Med, Durham, NC 27710 USA
[7] Durham VA Hlth Care Syst, Infect Dis Sect, Durham, NC 27705 USA
关键词
COVID-19; risk factor; mortality; smoking; PREVALENCE; CARE;
D O I
10.3390/ijerph18168486
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: We performed an observational Veterans Health Administration cohort analysis to assess how risk factors affect 30-day mortality in SARS-CoV-2-infected subjects relative to those uninfected. While the risk factors for coronavirus disease 2019 (COVID-19) have been extensively studied, these have been seldom compared with uninfected referents. Methods: We analyzed 341,166 White/Black male veterans tested for SARS-CoV-2 from March 1 to September 10, 2020. The relative risk of 30-day mortality was computed for age, race, ethnicity, BMI, smoking status, and alcohol use disorder in infected and uninfected subjects separately. The difference in relative risk was then evaluated between infected and uninfected subjects. All the analyses were performed considering clinical confounders. Results: In this cohort, 7% were SARS-CoV-2-positive. Age >60 and overweight/obesity were associated with a dose-related increased mortality risk among infected patients relative to those uninfected. In contrast, relative to never smoking, current smoking was associated with a decreased mortality among infected and an increased mortality in uninfected, yielding a reduced mortality risk among infected relative to uninfected. Alcohol use disorder was also associated with decreased mortality risk in infected relative to the uninfected. Conclusions: Age, BMI, smoking, and alcohol use disorder affect 30-day mortality in SARS-CoV-2-infected subjects differently from uninfected referents. Advanced age and overweight/obesity were associated with increased mortality risk among infected men, while current smoking and alcohol use disorder were associated with lower mortality risk among infected men, when compared with those uninfected.
引用
收藏
页数:13
相关论文
共 50 条
[41]   SARS-CoV-2/COVID-19-epidemiology and prevention [J].
Salzberger, Bernd ;
Buder, Felix ;
Lampl, Benedikt ;
Ehrenstein, Boris ;
Hitzenbichler, Florian ;
Holzmann, Thomas ;
Schmidt, Barbara ;
Hanses, Frank .
NEPHROLOGE, 2021, 16 (01) :3-9
[42]   Poverty and food insecurity in Amazonian children associated with SARS-CoV-2 infection and COVID-19 [J].
Cardoso, Marly Augusto ;
Giacomini, Isabel ;
Sato, Priscila Morais ;
Lourenco, Barbara Hatzlhoffer ;
Nicolete, Vanessa ;
Buss, Lewis ;
Matijasevich, Alicia ;
Castro, Marcia Caldas ;
Ferreira, Marcelo Urbano .
ANNALS OF NUTRITION AND METABOLISM, 2023, 79 :833-834
[43]   IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility [J].
Xu, Fengwen ;
Wang, Geng ;
Zhao, Fei ;
Huang, Yu ;
Fan, Zhangling ;
Mei, Shan ;
Xie, Yu ;
Wei, Liang ;
Hu, Yamei ;
Wang, Conghui ;
Cen, Shan ;
Liang, Chen ;
Ren, Lili ;
Guo, Fei ;
Wang, Jianwei .
VIRUSES-BASEL, 2022, 14 (11)
[44]   COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications [J].
Kalra, Rajkumar Singh ;
Dhanjal, Jaspreet Kaur ;
Meena, Avtar Singh ;
Kalel, Vishal C. ;
Dahiya, Surya ;
Singh, Birbal ;
Dewanjee, Saikat ;
Kandimalla, Ramesh .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[45]   SARS-CoV-2 associated viral encephalitis with mortality outcome [J].
Azab, Mohammed A. ;
Azzam, Ahmed Y. .
INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2021, 25
[46]   Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19) [J].
Carrascosa, J. M. ;
Morillas, V ;
Bielsa, I ;
Munera-Campos, M. .
ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (09) :734-742
[47]   Human genetics of SARS-CoV-2 infection and critical COVID-19 [J].
Mogensen, Trine H. .
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (11) :1417-1421
[48]   Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes [J].
Chiodini, Iacopo ;
Gatti, Davide ;
Soranna, Davide ;
Merlotti, Daniela ;
Mingiano, Christian ;
Fassio, Angelo ;
Adami, Giovanni ;
Falchetti, Alberto ;
Eller-Vainicher, Cristina ;
Rossini, Maurizio ;
Persani, Luca ;
Zambon, Antonella ;
Gennari, Luigi .
FRONTIERS IN PUBLIC HEALTH, 2021, 9
[49]   SARS-CoV-2 infection (COVID-19): What are we facing? [J].
Kern, Winfried, V ;
Biever, Paul M. ;
Rieg, Siegbert ;
Panning, Marcus .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (11) :740-746
[50]   Pharmacological options in treating SARS-CoV-2 infection/COVID-19 [J].
Fabian Akos ;
Laszlo Istvan ;
Juhasz Marianna ;
Berhes Mariann ;
Vegh Tamas ;
Koszta Gyorgy ;
Molnar Csilla ;
Fulesdi Bela .
ORVOSI HETILAP, 2020, 161 (17) :685-688